Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging

In order to evaluate the pattern of proton magnetic resonance spectroscopy ( 1H-MRS) in the gray and white matter of patients with Alzheimer's disease (AD) and healthy controls, a cross-sectional study was carried out on 13 consecutive AD patients and 7 healthy older subjects who were referred...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mechanisms of ageing and development 1997-07, Vol.97 (1), p.9-14
Hauptverfasser: Parnetti, Lucilla, Tarducci, Roberto, Presciutti, Otello, Lowenthal, David T, Pippi, Margherita, Palumbo, Barbara, Gobbi, Gianni, Pelliccioli, Gian Piero, Senin, Umberto
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 14
container_issue 1
container_start_page 9
container_title Mechanisms of ageing and development
container_volume 97
creator Parnetti, Lucilla
Tarducci, Roberto
Presciutti, Otello
Lowenthal, David T
Pippi, Margherita
Palumbo, Barbara
Gobbi, Gianni
Pelliccioli, Gian Piero
Senin, Umberto
description In order to evaluate the pattern of proton magnetic resonance spectroscopy ( 1H-MRS) in the gray and white matter of patients with Alzheimer's disease (AD) and healthy controls, a cross-sectional study was carried out on 13 consecutive AD patients and 7 healthy older subjects who were referred to the Day-Hospital for diagnostic assessment. All examinations were performed on a 1.5 Tesla whole-body scanner. Volumes of interest were selected in both the gray (temporal region) and the white (frontal region) matter. N-acetyl group, total creatine, total choline and myo-inositol were quantified referring the metabolite peak area to the unsuppressed water peak area acquired under the same conditions, and the ratio was expressed in arbitrary units. A significant decrease in N-acetyl–aspartate (NAA) in both gray and white matter and an increase in myo-inositol (mI) in gray matter of AD patients were observed. The gray matter NAA/mI ratio clearly separated the two groups. White matter mI was significantly associated with severity and duration of dementia. No association with age was documented. It can be concluded that in vivo 1H-MRS can contribute to the knowledge of pathophysiology of AD, giving neurochemical details of both gray and white matter. In particular, the gray matter NAA/mI ratio seems to be able to differentiate normal cerebral aging from Alzheimer's disease.
doi_str_mv 10.1016/S0047-6374(97)01877-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79136889</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0047637497018770</els_id><sourcerecordid>79136889</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-fd954b139db43b88e8d2a94352f8bfe2a34a80665780066b8d05426bc4f00c943</originalsourceid><addsrcrecordid>eNqFkF1LHDEUhkOx6Kr9CUIuirUXo0kmk48rEdFaECxUbxsymZNtZCbZJrMF--sb3WVvvTqB9znn5DwInVByTgkVFz8J4bIRreRnWn4lVEnZkA9oUR-sEYyKPbTYIQfosJRnQgjlTOyjfc1YSxlboF8_cppTxJNdRpiDwxlKijY6wGUFbs6puLR6wc5GPATvIUOcg50BX43_fkOYIH8pNSlgC2Cf04RjypMdsV2GuDxGH70dC3za1iP0dHvzeH3X3D98-359dd84zunc-EF3vKetHnre9kqBGpjVvO2YV70HZltuFRGik4rU0quBdPWQ3nFPiKvgETrdzF3l9GcNZTZTKA7G0UZI62Kkpq1QSlew24CuXlYyeLPKYbL5xVBiXr2aN6_mVZrR0rx5NaT2nWwXrPsJhl3XVmTNP29zW5wdfa4KQ9lhTFKmtKjY5QaDKuNvgGyKC1BtDyFX22ZI4Z2P_Af5h5UD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79136889</pqid></control><display><type>article</type><title>Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Parnetti, Lucilla ; Tarducci, Roberto ; Presciutti, Otello ; Lowenthal, David T ; Pippi, Margherita ; Palumbo, Barbara ; Gobbi, Gianni ; Pelliccioli, Gian Piero ; Senin, Umberto</creator><creatorcontrib>Parnetti, Lucilla ; Tarducci, Roberto ; Presciutti, Otello ; Lowenthal, David T ; Pippi, Margherita ; Palumbo, Barbara ; Gobbi, Gianni ; Pelliccioli, Gian Piero ; Senin, Umberto</creatorcontrib><description>In order to evaluate the pattern of proton magnetic resonance spectroscopy ( 1H-MRS) in the gray and white matter of patients with Alzheimer's disease (AD) and healthy controls, a cross-sectional study was carried out on 13 consecutive AD patients and 7 healthy older subjects who were referred to the Day-Hospital for diagnostic assessment. All examinations were performed on a 1.5 Tesla whole-body scanner. Volumes of interest were selected in both the gray (temporal region) and the white (frontal region) matter. N-acetyl group, total creatine, total choline and myo-inositol were quantified referring the metabolite peak area to the unsuppressed water peak area acquired under the same conditions, and the ratio was expressed in arbitrary units. A significant decrease in N-acetyl–aspartate (NAA) in both gray and white matter and an increase in myo-inositol (mI) in gray matter of AD patients were observed. The gray matter NAA/mI ratio clearly separated the two groups. White matter mI was significantly associated with severity and duration of dementia. No association with age was documented. It can be concluded that in vivo 1H-MRS can contribute to the knowledge of pathophysiology of AD, giving neurochemical details of both gray and white matter. In particular, the gray matter NAA/mI ratio seems to be able to differentiate normal cerebral aging from Alzheimer's disease.</description><identifier>ISSN: 0047-6374</identifier><identifier>EISSN: 1872-6216</identifier><identifier>DOI: 10.1016/S0047-6374(97)01877-0</identifier><identifier>PMID: 9223122</identifier><identifier>CODEN: MAGDA3</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>1H-MRS ; Aged ; Aged, 80 and over ; Aging - pathology ; Aging brain ; Alzheimer Disease - diagnosis ; Alzheimer's disease ; Biological and medical sciences ; Brain - pathology ; Case-Control Studies ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Diagnosis, Differential ; Female ; Humans ; Magnetic Resonance Spectroscopy - methods ; Male ; Medical sciences ; Middle Aged ; Myo-inositol ; N-acetyl–aspartate ; Neurology ; Proton magnetic resonance spectroscopy ; Protons ; Reference Values</subject><ispartof>Mechanisms of ageing and development, 1997-07, Vol.97 (1), p.9-14</ispartof><rights>1997 Elsevier Science Ireland Ltd</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-fd954b139db43b88e8d2a94352f8bfe2a34a80665780066b8d05426bc4f00c943</citedby><cites>FETCH-LOGICAL-c441t-fd954b139db43b88e8d2a94352f8bfe2a34a80665780066b8d05426bc4f00c943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0047-6374(97)01877-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2712896$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9223122$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Parnetti, Lucilla</creatorcontrib><creatorcontrib>Tarducci, Roberto</creatorcontrib><creatorcontrib>Presciutti, Otello</creatorcontrib><creatorcontrib>Lowenthal, David T</creatorcontrib><creatorcontrib>Pippi, Margherita</creatorcontrib><creatorcontrib>Palumbo, Barbara</creatorcontrib><creatorcontrib>Gobbi, Gianni</creatorcontrib><creatorcontrib>Pelliccioli, Gian Piero</creatorcontrib><creatorcontrib>Senin, Umberto</creatorcontrib><title>Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging</title><title>Mechanisms of ageing and development</title><addtitle>Mech Ageing Dev</addtitle><description>In order to evaluate the pattern of proton magnetic resonance spectroscopy ( 1H-MRS) in the gray and white matter of patients with Alzheimer's disease (AD) and healthy controls, a cross-sectional study was carried out on 13 consecutive AD patients and 7 healthy older subjects who were referred to the Day-Hospital for diagnostic assessment. All examinations were performed on a 1.5 Tesla whole-body scanner. Volumes of interest were selected in both the gray (temporal region) and the white (frontal region) matter. N-acetyl group, total creatine, total choline and myo-inositol were quantified referring the metabolite peak area to the unsuppressed water peak area acquired under the same conditions, and the ratio was expressed in arbitrary units. A significant decrease in N-acetyl–aspartate (NAA) in both gray and white matter and an increase in myo-inositol (mI) in gray matter of AD patients were observed. The gray matter NAA/mI ratio clearly separated the two groups. White matter mI was significantly associated with severity and duration of dementia. No association with age was documented. It can be concluded that in vivo 1H-MRS can contribute to the knowledge of pathophysiology of AD, giving neurochemical details of both gray and white matter. In particular, the gray matter NAA/mI ratio seems to be able to differentiate normal cerebral aging from Alzheimer's disease.</description><subject>1H-MRS</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aging - pathology</subject><subject>Aging brain</subject><subject>Alzheimer Disease - diagnosis</subject><subject>Alzheimer's disease</subject><subject>Biological and medical sciences</subject><subject>Brain - pathology</subject><subject>Case-Control Studies</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Diagnosis, Differential</subject><subject>Female</subject><subject>Humans</subject><subject>Magnetic Resonance Spectroscopy - methods</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myo-inositol</subject><subject>N-acetyl–aspartate</subject><subject>Neurology</subject><subject>Proton magnetic resonance spectroscopy</subject><subject>Protons</subject><subject>Reference Values</subject><issn>0047-6374</issn><issn>1872-6216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF1LHDEUhkOx6Kr9CUIuirUXo0kmk48rEdFaECxUbxsymZNtZCbZJrMF--sb3WVvvTqB9znn5DwInVByTgkVFz8J4bIRreRnWn4lVEnZkA9oUR-sEYyKPbTYIQfosJRnQgjlTOyjfc1YSxlboF8_cppTxJNdRpiDwxlKijY6wGUFbs6puLR6wc5GPATvIUOcg50BX43_fkOYIH8pNSlgC2Cf04RjypMdsV2GuDxGH70dC3za1iP0dHvzeH3X3D98-359dd84zunc-EF3vKetHnre9kqBGpjVvO2YV70HZltuFRGik4rU0quBdPWQ3nFPiKvgETrdzF3l9GcNZTZTKA7G0UZI62Kkpq1QSlew24CuXlYyeLPKYbL5xVBiXr2aN6_mVZrR0rx5NaT2nWwXrPsJhl3XVmTNP29zW5wdfa4KQ9lhTFKmtKjY5QaDKuNvgGyKC1BtDyFX22ZI4Z2P_Af5h5UD</recordid><startdate>19970701</startdate><enddate>19970701</enddate><creator>Parnetti, Lucilla</creator><creator>Tarducci, Roberto</creator><creator>Presciutti, Otello</creator><creator>Lowenthal, David T</creator><creator>Pippi, Margherita</creator><creator>Palumbo, Barbara</creator><creator>Gobbi, Gianni</creator><creator>Pelliccioli, Gian Piero</creator><creator>Senin, Umberto</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19970701</creationdate><title>Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging</title><author>Parnetti, Lucilla ; Tarducci, Roberto ; Presciutti, Otello ; Lowenthal, David T ; Pippi, Margherita ; Palumbo, Barbara ; Gobbi, Gianni ; Pelliccioli, Gian Piero ; Senin, Umberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-fd954b139db43b88e8d2a94352f8bfe2a34a80665780066b8d05426bc4f00c943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>1H-MRS</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aging - pathology</topic><topic>Aging brain</topic><topic>Alzheimer Disease - diagnosis</topic><topic>Alzheimer's disease</topic><topic>Biological and medical sciences</topic><topic>Brain - pathology</topic><topic>Case-Control Studies</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Diagnosis, Differential</topic><topic>Female</topic><topic>Humans</topic><topic>Magnetic Resonance Spectroscopy - methods</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myo-inositol</topic><topic>N-acetyl–aspartate</topic><topic>Neurology</topic><topic>Proton magnetic resonance spectroscopy</topic><topic>Protons</topic><topic>Reference Values</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Parnetti, Lucilla</creatorcontrib><creatorcontrib>Tarducci, Roberto</creatorcontrib><creatorcontrib>Presciutti, Otello</creatorcontrib><creatorcontrib>Lowenthal, David T</creatorcontrib><creatorcontrib>Pippi, Margherita</creatorcontrib><creatorcontrib>Palumbo, Barbara</creatorcontrib><creatorcontrib>Gobbi, Gianni</creatorcontrib><creatorcontrib>Pelliccioli, Gian Piero</creatorcontrib><creatorcontrib>Senin, Umberto</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Mechanisms of ageing and development</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Parnetti, Lucilla</au><au>Tarducci, Roberto</au><au>Presciutti, Otello</au><au>Lowenthal, David T</au><au>Pippi, Margherita</au><au>Palumbo, Barbara</au><au>Gobbi, Gianni</au><au>Pelliccioli, Gian Piero</au><au>Senin, Umberto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging</atitle><jtitle>Mechanisms of ageing and development</jtitle><addtitle>Mech Ageing Dev</addtitle><date>1997-07-01</date><risdate>1997</risdate><volume>97</volume><issue>1</issue><spage>9</spage><epage>14</epage><pages>9-14</pages><issn>0047-6374</issn><eissn>1872-6216</eissn><coden>MAGDA3</coden><abstract>In order to evaluate the pattern of proton magnetic resonance spectroscopy ( 1H-MRS) in the gray and white matter of patients with Alzheimer's disease (AD) and healthy controls, a cross-sectional study was carried out on 13 consecutive AD patients and 7 healthy older subjects who were referred to the Day-Hospital for diagnostic assessment. All examinations were performed on a 1.5 Tesla whole-body scanner. Volumes of interest were selected in both the gray (temporal region) and the white (frontal region) matter. N-acetyl group, total creatine, total choline and myo-inositol were quantified referring the metabolite peak area to the unsuppressed water peak area acquired under the same conditions, and the ratio was expressed in arbitrary units. A significant decrease in N-acetyl–aspartate (NAA) in both gray and white matter and an increase in myo-inositol (mI) in gray matter of AD patients were observed. The gray matter NAA/mI ratio clearly separated the two groups. White matter mI was significantly associated with severity and duration of dementia. No association with age was documented. It can be concluded that in vivo 1H-MRS can contribute to the knowledge of pathophysiology of AD, giving neurochemical details of both gray and white matter. In particular, the gray matter NAA/mI ratio seems to be able to differentiate normal cerebral aging from Alzheimer's disease.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>9223122</pmid><doi>10.1016/S0047-6374(97)01877-0</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0047-6374
ispartof Mechanisms of ageing and development, 1997-07, Vol.97 (1), p.9-14
issn 0047-6374
1872-6216
language eng
recordid cdi_proquest_miscellaneous_79136889
source MEDLINE; Elsevier ScienceDirect Journals
subjects 1H-MRS
Aged
Aged, 80 and over
Aging - pathology
Aging brain
Alzheimer Disease - diagnosis
Alzheimer's disease
Biological and medical sciences
Brain - pathology
Case-Control Studies
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Diagnosis, Differential
Female
Humans
Magnetic Resonance Spectroscopy - methods
Male
Medical sciences
Middle Aged
Myo-inositol
N-acetyl–aspartate
Neurology
Proton magnetic resonance spectroscopy
Protons
Reference Values
title Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T14%3A46%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Proton%20magnetic%20resonance%20spectroscopy%20can%20differentiate%20Alzheimer's%20disease%20from%20normal%20aging&rft.jtitle=Mechanisms%20of%20ageing%20and%20development&rft.au=Parnetti,%20Lucilla&rft.date=1997-07-01&rft.volume=97&rft.issue=1&rft.spage=9&rft.epage=14&rft.pages=9-14&rft.issn=0047-6374&rft.eissn=1872-6216&rft.coden=MAGDA3&rft_id=info:doi/10.1016/S0047-6374(97)01877-0&rft_dat=%3Cproquest_cross%3E79136889%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79136889&rft_id=info:pmid/9223122&rft_els_id=S0047637497018770&rfr_iscdi=true